Michaël Bosco

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Molecular Dynamics Simulations

Multidrug Resistant

Cystic Fibrosis

Methicillin Resistant Staphylococcus Aureus

Top Venues

Molecules (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

Organic & biomolecular chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Hongwei Wan, Raja Ben Othman, Laurent Le Corre, Mélanie Poinsot, Martin Oliver, Ana Amoroso, Bernard Joris, Thierry Touzé, Rodolphe Auger, Sandrine Calvet-Vitale, Michaël Bosco, Christine Gravier-Pelletier
New MraY AA Inhibitors with an Aminoribosyl Uridine Structure and an Oxadiazole. Antibiotics (Basel, Switzerland) 11 (9) (2022)
Martin Oliver, Laurent Le Corre, Mélanie Poinsot, Michaël Bosco, Hongwei Wan, Ana Amoroso, Bernard Joris, Ahmed Bouhss, Sandrine Calvet-Vitale, Christine Gravier-Pelletier
A Sub-Micromolar MraY AA Inhibitor with an Aminoribosyl Uridine Structure and a ( S , S )-Tartaric Diamide: Synthesis, Biological Evaluation and Molecular Modeling. Molecules (Basel, Switzerland) 27 (6) (2022)
Martin Oliver, Laurent Le Corre, Mélanie Poinsot, Alessandra Corio, Léa Madegard, Michaël Bosco, Ana Amoroso, Bernard Joris, Rodolphe Auger, Thierry Touzé, Ahmed Bouhss, Sandrine Calvet-Vitale, Christine Gravier-Pelletier
Synthesis, biological evaluation and molecular modeling of urea-containing MraY inhibitors. Organic & biomolecular chemistry 19 (26) (2021)
Michaël Bosco, Su-Jin Paik, Patricia Busca, Stuart E H Moore, Christine Gravier-Pelletier
Synthetic Route to Glycosyl β-1C-(phosphino)-phosphonates as Unprecedented Stable Glycosyl Diphosphate Analogs and Their Preliminary Biological Evaluation. Molecules (Basel, Switzerland) 25 (21) (2020)